Moxifloxacin vs Upadacitinib
Moxifloxacin vs Upadacitinib: Overview
This comparison examines the pharmacological differences between Moxifloxacin and Upadacitinib.
Mechanism of Action
Moxifloxacin: Fourth-generation fluoroquinolone inhibiting DNA gyrase and topoisomerase IV with enhanced anaerobic activity.
Upadacitinib: Selective JAK1 inhibitor reducing signaling from cytokines implicated in autoimmune diseases.
Pharmacokinetics
Half-life: Moxifloxacin — 12 hours; Upadacitinib — 9-14 hours.
Chemical Properties
Molecular Formula: Moxifloxacin — C21H24FN3O4; Upadacitinib — C17H19F3N6O.
Molecular Weight: Moxifloxacin — 401.4350 g/mol; Upadacitinib — 380.3700 g/mol.
Type: Moxifloxacin — Small molecule; Upadacitinib — Small molecule.